← All trials
NCT00781898
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2008
- Primary completion
- Aug 1, 2015
- Completion date
- Aug 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 308
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of PennsylvaniaLead sponsor
- University of PennsylvaniaOverall official - principal investigator
- Rhode Island HospitalOverall official - principal investigator
- Mountain Manor Treatment Center, Baltimore MDOverall official - principal investigator
- New York UniversityOverall official - principal investigator
- Columbia UniversityOverall official - principal investigator
- National Institute on Drug Abuse (NIDA)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.